EndoDrug: A new AI-based cell invasion platform for accelerated diagnosis and drug testing in endometriosis

Forschungsstelle

INNOSUISSE

Projektnummer

125.876 IP-LS

Projekttitel

EndoDrug: A new AI-based cell invasion platform for accelerated diagnosis and drug testing in endometriosis

Projekttitel Englisch

EndoDrug: A new AI-based cell invasion platform for accelerated diagnosis and drug testing in endometriosis

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Pharmaceuticals
Abstract (Englisch)	Endometriosis poses a significant global health burden with treatment progress limited by the lack of in vitro models that replicate early-stage cell invasion. EndoDrug addresses this need by developing an AI-assisted in vitro organoid invasion platform for endometriosis diagnosis and drug testing.